PIK3CA and head and neck cancer: Of these driver genes, driver mutations of PIK3CA [23] and KEAP1/NFE2L2 [24] have already been demonstrated to be associated with APOBEC signature enrichment, and PIK3CA variants have furthermore been demonstrated to possess high APOBEC-mutation-driven effect sizes in head and neck cancer [25].